Lack of PSD‐95 drives hippocampal neuronal cell death through activation of an αCaMKII transduction pathway
- 1 September 2002
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 16 (5) , 777-786
- https://doi.org/10.1046/j.1460-9568.2002.02141.x
Abstract
The PSD-95 protein family organizes the glutamatergic postsynaptic density and it is involved in the regulation of the excitatory signal at central nervous system synapses. We show here that PSD-95 deficiency by means of antisense oligonucleotides induces significant neuronal cell death within 24 h both in primary hippocampal cultures and in organotypic hippocampal slices. On the other hand, cultured cortical neurons are spared by PSD-95 antisense toxicity until they reach a NR2A detectable protein level (24 days in vitro). The neurotoxic event is characterized by increased alpha CaMKII association to NR2 regulatory subunits of NMDA receptor complex. As a direct consequence of alpha CaMKII association, we found increased GluR1 delivery to cell surface in cultured hippocampal neurons paralleled by AMPA-dependent increase in [Na+]I levels. In addition, both CaMKII specific inhibitor KN-93 and AMPA receptor antagonists CNQX and NBQX rescued neuronal survival to control values. On the other hand, both the NMDA channel blocker MK-801 and Dantrolene, an inhibitor of calcium release from ryanodine-sensitive endoplasmic reticulum stores, failed to have any effect on neuronal survival in PSD-95 deficient neurons. Thus, our data provide clues that PSD-95 reduced expression in neurons is responsible for neuronal vulnerability mediated by direct activation of alpha CaMKII transduction pathway in the postsynaptic compartment.Keywords
This publication has 31 references indexed in Scilit:
- A Model of Synaptic MemoryNeuron, 2001
- Interaction with the NMDA receptor locks CaMKII in an active conformationNature, 2001
- Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons.Published by Elsevier ,2001
- Driving AMPA Receptors into Synapses by LTP and CaMKII: Requirement for GluR1 and PDZ Domain InteractionScience, 2000
- An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and EpilepsyScience, 2000
- 1‐Aminoindan‐1,5‐dicarboxylic acid and (S)‐(+)‐2‐(3′‐carboxybicyclo[1.1.1] pentyl)‐glycine, two mGlu1 receptor‐preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemiaEuropean Journal of Neuroscience, 1999
- αCaMKII binding to the C‐terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylationFEBS Letters, 1999
- SAP97 Is Associated with the α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor GluR1 SubunitJournal of Biological Chemistry, 1998
- Domain Interaction Between NMDA Receptor Subunits and the Postsynaptic Density Protein PSD-95Science, 1995
- Cloned Glutamate ReceptorsAnnual Review of Neuroscience, 1994